Halothane-induced hepatitis: paradigm or paradox for drug-induced liver injury.
作者信息
Kurth Mark J, Yokoi Tsuyoshi, Gershwin M Eric
机构信息
Department of Chemistry, University of California at Davis, Davis, CA.
出版信息
Hepatology. 2014 Nov;60(5):1473-5. doi: 10.1002/hep.27253. Epub 2014 Sep 25.
Abstract
摘要
相似文献
1
Halothane-induced hepatitis: paradigm or paradox for drug-induced liver injury.氟烷性肝炎：药物性肝损伤的范例还是悖论
Hepatology. 2014 Nov;60(5):1473-5. doi: 10.1002/hep.27253. Epub 2014 Sep 25.
2
Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice.胸腺基质淋巴细胞生成素和白细胞介素-4介导小鼠氟烷诱导的肝损伤发病机制。
Hepatology. 2014 Nov;60(5):1741-52. doi: 10.1002/hep.27169. Epub 2014 May 20.
3
Halothane and post-halothane exposure hepatitis.氟烷与氟烷暴露后肝炎
N Z Med J. 1999 Jan 22;112(1080):19-20.
4
Halothane hepatitis.氟烷性肝炎
Eur J Gastroenterol Hepatol. 1998 Aug;10(8):631-3.
5
Hypothesis: halothane hepatitis--has thymol been overlooked?假设：氟烷性肝炎——麝香草酚被忽视了吗？
Anaesthesia. 1995 Dec;50(12):1098. doi: 10.1111/j.1365-2044.1995.tb05974.x.
6
Molecular basis of halothane hepatitis.氟烷性肝炎的分子基础。
Arch Toxicol Suppl. 1998;20:3-17. doi: 10.1007/978-3-642-46856-8_1.
7
Halothane: the last word?氟烷：定论了吗？
Paediatr Anaesth. 2001 Mar;11(2):252. doi: 10.1046/j.1460-9592.2001.0666c.x.
8
Isoflurane hepatotoxicity in a patient with a previous history of halothane-induced hepatitis.一名有氟烷诱导性肝炎病史患者的异氟烷肝毒性。
Hepatogastroenterology. 1998 Mar-Apr;45(20):518-22.
9
Halothane induced hepatitis: case report.氟烷性肝炎：病例报告。
East Afr Med J. 2004 Oct;81(10):538-9. doi: 10.4314/eamj.v81i10.9238.
10
Halothane induced fulminant hepatic failure.氟烷诱发暴发性肝衰竭。
J Coll Physicians Surg Pak. 2007 Feb;17(2):103-4.
引用本文的文献
1
Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes.药物在人药物代谢酶催化反应中形成潜在毒性代谢物。
Arch Toxicol. 2024 Jun;98(6):1581-1628. doi: 10.1007/s00204-024-03710-9. Epub 2024 Mar 23.
2
Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation.通过半抗原化引起的化学和药物诱导的过敏性、炎症性和自身免疫性疾病。
Biology (Basel). 2023 Jan 12;12(1):123. doi: 10.3390/biology12010123.
3
Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms.自身免疫性肝炎的发病机制-细胞和分子机制。
Int J Mol Sci. 2021 Dec 17;22(24):13578. doi: 10.3390/ijms222413578.
4
Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.人类家族 1-4 细胞色素 P450 酶参与外源化学物和生理化学物质的代谢激活：更新。
Arch Toxicol. 2021 Feb;95(2):395-472. doi: 10.1007/s00204-020-02971-4. Epub 2021 Jan 18.
5
In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.在药物诱导的免疫介导性肝炎中，白细胞介素-33 通过独立于 FoxP3+T 细胞活性以及通过其介导的 FoxP3+T 细胞活性来减轻肝炎并改善生存率。
Cell Mol Immunol. 2019 Aug;16(8):706-717. doi: 10.1038/s41423-018-0087-y. Epub 2018 Jul 20.
6
Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury.中药及草药性肝损伤：与药物性肝损伤的比较
J Clin Transl Hepatol. 2018 Mar 28;6(1):57-68. doi: 10.14218/JCTH.2017.00033. Epub 2017 Oct 27.
7
Mechanistic Modelling of Drug-Induced Liver Injury: Investigating the Role of Innate Immune Responses.药物性肝损伤的机制建模：探究固有免疫反应的作用
Gene Regul Syst Bio. 2017 May 30;11:1177625017696074. doi: 10.1177/1177625017696074. eCollection 2017.
8
Adaptive immunity in the liver.肝脏中的适应性免疫。
Cell Mol Immunol. 2016 May;13(3):354-68. doi: 10.1038/cmi.2016.4. Epub 2016 Mar 21.
9
Xenobiotics and loss of tolerance in primary biliary cholangitis.异生物素与原发性胆汁性胆管炎中的耐受性丧失
World J Gastroenterol. 2016 Jan 7;22(1):338-48. doi: 10.3748/wjg.v22.i1.338.
10
The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis.循环外泌体对原发性胆汁性肝硬化中共刺激分子的调节作用
Cell Mol Immunol. 2017 Mar;14(3):276-284. doi: 10.1038/cmi.2015.86. Epub 2015 Sep 21.
本文引用的文献
1
Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice.胸腺基质淋巴细胞生成素和白细胞介素-4介导小鼠氟烷诱导的肝损伤发病机制。
Hepatology. 2014 Nov;60(5):1741-52. doi: 10.1002/hep.27169. Epub 2014 May 20.
2
Involvement of miRNAs in the early phase of halothane-induced liver injury.微小RNA在氟烷诱导的肝损伤早期阶段的作用。
Toxicology. 2014 May 7;319:75-84. doi: 10.1016/j.tox.2014.02.011. Epub 2014 Mar 2.
3
Basophils and allergic inflammation.嗜碱性粒细胞与过敏炎症。
J Allergy Clin Immunol. 2013 Oct;132(4):789-801; quiz 788. doi: 10.1016/j.jaci.2013.07.046.
4
Thymic stromal lymphopoietin over-expressed in human atherosclerosis: potential role in Th17 differentiation.
Cell Physiol Biochem. 2013;31(2-3):305-18. doi: 10.1159/000343369. Epub 2013 Feb 28.
5
The biology of thymic stromal lymphopoietin (TSLP).胸腺基质淋巴细胞生成素（TSLP）的生物学特性
Adv Pharmacol. 2013;66:129-55. doi: 10.1016/B978-0-12-404717-4.00004-4.
6
Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice.嗜酸性粒细胞介导氟烷诱导的小鼠肝损伤发病机制。
Hepatology. 2013 May;57(5):2026-36. doi: 10.1002/hep.26196. Epub 2013 Mar 15.
7
Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes.丙型肝炎病毒通过感染肝细胞产生胸腺基质淋巴细胞生成素促进辅助性 T 细胞 17 反应。
Hepatology. 2013 Apr;57(4):1314-24. doi: 10.1002/hep.26128. Epub 2013 Mar 14.
8
Multiple-checkpoint inhibition of thymic stromal lymphopoietin-induced TH2 response by TH17-related cytokines.多种细胞检查点抑制物通过 TH17 相关细胞因子抑制胸腺基质淋巴细胞生成素诱导的 TH2 反应。
J Allergy Clin Immunol. 2012 Jul;130(1):233-40.e5. doi: 10.1016/j.jaci.2012.04.038. Epub 2012 Jun 2.
9
Twin studies in autoimmune disease: genetics, gender and environment.自身免疫性疾病的双胞胎研究：遗传学、性别和环境。
J Autoimmun. 2012 May;38(2-3):J156-69. doi: 10.1016/j.jaut.2011.11.003. Epub 2011 Dec 15.
10
Naringenin suppresses the production of thymic stromal lymphopoietin through the blockade of RIP2 and caspase-1 signal cascade in mast cells.柚皮素通过阻断肥大细胞中的 RIP2 和 caspase-1 信号级联来抑制胸腺基质淋巴细胞生成素的产生。
Eur J Pharmacol. 2011 Dec 5;671(1-3):128-32. doi: 10.1016/j.ejphar.2011.09.163. Epub 2011 Sep 24.
Zotero 插件